Drugs / Abacavir/Lamivudine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01263015 | Feb 2011 → May 2012 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | abacavir-lamivudine | “Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.” PMID 26262777 ↗ Dec 2015 |